Document Detail


Papaverine delivery to the internal mammary artery pedicle effectively treats spasm.
MedLine Citation:
PMID:  15464488     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Left internal mammary artery spasm is well recognized during coronary artery bypass operations. Papaverine has been used by many surgeons to maximize mammary artery flow perioperatively, but the best delivery method is not known. We analyzed two techniques used at our institution. METHODS: Fifty-eight patients were randomized into three groups to compare papaverine's ability to prevent spasm and to treat established spasm. Group 1 was control and no treatment was employed. In group 2, papaverine was injected with a blunt needle through the endothoracic fascia parallel to the mammary artery before harvest to assess spasm prevention. In group 3, papaverine was delivered perivascular in an identical manner to group 2 but after the mammary artery was dissected from the chest wall. This group was an evaluation of spasm treatment. Drug dosage was the same for both groups and routine bypass grafting was performed. Before anastomosing the mammary artery to the left anterior descending artery, blood flow was recorded for 15 seconds and flow per minute calculated. Cardiopulmonary bypass pressures were maintained at 70 mm Hg during collection. RESULTS: Mean blood flows were: group 1 = 86.2 mL/min, group 2 = 122.5 mL/min, and group 3 = 139.7 mL/min. Left internal mammary artery flow in group 3 was statistically different from control (p = 0.0457). Group 2 flow approached but did not reach statistical significance (p = 0.0874). Mammary artery dissection times for the three groups were not different. CONCLUSIONS: Papaverine delivery to the left internal mammary artery after dissection treats spasm effectively, improves blood flow at the time of its anastamosis to the left anterior descending artery, and avoids any risk of intimal injury. Injection of papaverine before mammary artery harvest does not shorten dissection time, and flow is not statistically improved.
Authors:
Dhru S Girard; John P Sutton; Timothy H Williams; Arthur J Crumbley; James L Zellner; John M Kratz; Fred A Crawford
Related Documents :
6457988 - Investigations on the morphophysiological basis of revascularization of the myocardium ...
16429908 - Arterial conduits should be evaluated preoperatively in coronary artery bypass patients...
15194028 - Results of angioplasty (with or without stent) at the site of a narrowed coronary anast...
12538118 - Midterm angiographic results of off-pump coronary artery bypass grafting.
14627318 - Percutaneous transaortic occlusion of patent ductus arteriosus using a new versatile an...
7230268 - Asymptomatic continuous murmur due to acquired coronary artery to right ventricular fis...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  78     ISSN:  1552-6259     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  2004 Oct 
Date Detail:
Created Date:  2004-10-06     Completed Date:  2005-06-30     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  1295-8     Citation Subset:  AIM; IM    
Affiliation:
Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, South Carolina 29425-2279, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Arterial Occlusive Diseases / drug therapy*,  prevention & control
Female
Humans
Injections / methods
Internal Mammary-Coronary Artery Anastomosis*
Intraoperative Complications / drug therapy*,  prevention & control
Male
Mammary Arteries / drug effects*,  physiopathology,  transplantation
Muscle, Smooth, Vascular / drug effects,  physiopathology
Papaverine / administration & dosage*,  therapeutic use
Spasm / drug therapy,  prevention & control
Tissue and Organ Harvesting / methods
Vasoconstriction / drug effects*
Vasodilator Agents / administration & dosage*,  therapeutic use
Chemical
Reg. No./Substance:
0/Vasodilator Agents; 58-74-2/Papaverine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Flow dynamics of the internal thoracic and radial artery T-graft.
Next Document:  Prostacyclin reduces incidence of myocardial damage after coronary endarterectomy.